Montauk Renewables (MNTK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 22, 2025, at 9:00 a.m. EDT, to be held virtually for all shareholders.
Proxy materials, including the Proxy Statement and Annual Report, are available online and by request for all shareholders, including those registered in South Africa.
Voting is encouraged prior to the meeting, with specific deadlines for U.S. and South African shareholders.
Voting matters and shareholder proposals
Election of two nominees, Theventheran G. Govender and Yunis Shaik, to the Board of Directors as Class II directors for a three-year term expiring at the 2028 Annual Meeting.
Ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
Shareholders on the South African register are subject to specific share transfer restrictions around the meeting date.
Latest events from Montauk Renewables
- Net income plunged on flat revenue as RIN prices fell, but 2026 guidance expects growth.MNTK
Q4 202512 Mar 2026 - Q2 revenue dropped 18.6% on delayed RIN sales, but 2024 guidance and project pipeline remain strong.MNTK
Q2 20241 Feb 2026 - Q3 2024 revenue up 18.4% and net income up 31.8%, but project delays persist.MNTK
Q3 202414 Jan 2026 - Net income fell 34.9% to $9.7M on flat revenue, with 2025 RNG revenue guidance at $150–$170M.MNTK
Q4 202426 Dec 2025 - Director elections, auditor ratification, and strategic growth initiatives highlight the 2025 meeting.MNTK
Proxy Filing1 Dec 2025 - Revenue up 9.8%, but net loss and regulatory delays challenge outlook; major capex planned.MNTK
Q1 202526 Nov 2025 - Q2 2025 revenue rose 4.1% but net loss widened on lower RIN prices and higher costs.MNTK
Q2 202523 Nov 2025 - Q3 2025 revenue and net income fell sharply on lower RIN sales and prices; capex remains high.MNTK
Q3 202513 Nov 2025